Regenex Corporation engages in the reproductive health drug development business.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 24, 2018 | Series B | ¥20M | 1 | — | — | Detail |
Aug 11, 2017 | Series A | ¥10M | 1 | — | — | Detail |
Jul 15, 2016 | Angel | ¥3M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Taizhou Huaxin Venture Capital Management | — | Series B |
Taizhou Rongjianda | — | Series A |
Tongren Boda | — | Angel |